<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>INTERFERONS  ALFA</title><link>http://www.unboundmedicine.com/medline/ebm/research/INTERFERONS__ALFA</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19864682/full_citation/Peginterferon_alfa_2b_or_alfa_2a_with_ribavirin_for_hepatitis_C_</link><description>Hsu CS, Kao JH <br/><span class="title">Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. [Comment, Letter]</span><br/><span class="source" title="The New England journal of medicine">N Engl J Med 2009 Oct 29; 361(18):1808-9; author reply 1809.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19864682/full_citation/Peginterferon_alfa_2b_or_alfa_2a_with_ribavirin_for_hepatitis_C_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19864682/Peginterferon_alfa_2b_or_alfa_2a_with_ribavirin_for_hepatitis_C_">Find Related Articles</a> </description></item><item><title>Ribavirin Plasma Concentration Predicts Sustained Virological Response to Peginterferon Alfa 2a Plus Ribavirin in Previously Treated HCV-HIV-Coinfected Patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19858925/full_citation/Ribavirin_Plasma_Concentration_Predicts_Sustained_Virological_Response_to_Peginterferon_Alfa_2a_Plus_Ribavirin_in_Previously_Treated_HCV_HIV_Coinfected_Patients_</link><description>Breilh D, Djabarouti S, Trimoulet P, et al. <br/><span class="title">Ribavirin Plasma Concentration Predicts Sustained Virological Response to Peginterferon Alfa 2a Plus Ribavirin in Previously Treated HCV-HIV-Coinfected Patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2009 Nov; 52(3):428-430.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19858925/full_citation/Ribavirin_Plasma_Concentration_Predicts_Sustained_Virological_Response_to_Peginterferon_Alfa_2a_Plus_Ribavirin_in_Previously_Treated_HCV_HIV_Coinfected_Patients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19858925/Ribavirin_Plasma_Concentration_Predicts_Sustained_Virological_Response_to_Peginterferon_Alfa_2a_Plus_Ribavirin_in_Previously_Treated_HCV_HIV_Coinfected_Patients_">Find Related Articles</a> </description></item><item><title>MicroRNA expression, survival, and response to interferon in liver cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19812400/full_citation/MicroRNA_expression_survival_and_response_to_interferon_in_liver_cancer_</link><description>Ji J, Shi J, Budhu A, et al. <br/><span class="title">MicroRNA expression, survival, and response to interferon in liver cancer. [Journal Article, Research Support, N.I.H., Intramural]</span><br/><span class="source" title="The New England journal of medicine">N Engl J Med 2009 Oct 8; 361(15):1437-47.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19812400/abstract/MicroRNA_expression_survival_and_response_to_interferon_in_liver_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19812400/full_citation/MicroRNA_expression_survival_and_response_to_interferon_in_liver_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19812400/MicroRNA_expression_survival_and_response_to_interferon_in_liver_cancer_">Find Related Articles</a> </description></item><item><title>Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19788675/full_citation/Pegylated_interferon_and_ribavirin_therapy_for_hepatitis_C_causing_cataract_</link><description>Ku JY, Sharma A <br/><span class="title">Pegylated interferon and ribavirin therapy for hepatitis C causing cataract. [Letter]</span><br/><span class="source" title="Clinical &amp; experimental ophthalmology">Clin Experiment Ophthalmol 2009 Sep; 37(7):743-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19788675/full_citation/Pegylated_interferon_and_ribavirin_therapy_for_hepatitis_C_causing_cataract_">Full Citation</a> | <a href="http://www3.interscience.wiley.com/resolve/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=1442-6404%26amp;date=2009%26amp;volume=37%26amp;issue=7%26amp;spage=743">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19788675/Pegylated_interferon_and_ribavirin_therapy_for_hepatitis_C_causing_cataract_">Find Related Articles</a> </description></item><item><title>Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19787818/full_citation/Hepatitis_C_virus_infection_and_its_clearance_alter_circulating_lipids:_Implications_for_long_term_follow_up_</link><description>Corey KE, Kane E, Munroe C, et al. <br/><span class="title">Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up. [JOURNAL ARTICLE]</span><br/><span class="source" title="Hepatology (Baltimore, Md.)">Hepatology 2009 Aug 10; 50(4):1030-1037.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19787818/abstract/Hepatitis_C_virus_infection_and_its_clearance_alter_circulating_lipids:_Implications_for_long_term_follow_up_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19787818/full_citation/Hepatitis_C_virus_infection_and_its_clearance_alter_circulating_lipids:_Implications_for_long_term_follow_up_">Full Citation</a></description></item><item><title>Hepatitis C drug development at a crossroads.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19787813/full_citation/Hepatitis_C_drug_development_at_a_crossroads_</link><description>Nelson DR <br/><span class="title">Hepatitis C drug development at a crossroads. [JOURNAL ARTICLE]</span><br/><span class="source" title="Hepatology (Baltimore, Md.)">Hepatology 2009 Aug 5; 50(4):997-999.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19787813/full_citation/Hepatitis_C_drug_development_at_a_crossroads_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19787813/Hepatitis_C_drug_development_at_a_crossroads_">Find Related Articles</a> </description></item><item><title>Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19772388/full_citation/Efficacy_and_Safety_of_Pegylated_Interferon_plus_Ribavirin_in_HIV_and_Hepatitis_C_Virus_Coinfected_Patients_with_Advanced_Immunosuppression_</link><description>Mira JA, Gutiérrez-Valencia A, Gil ID, et al. <br/><span class="title">Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2009 Sep 22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19772388/abstract/Efficacy_and_Safety_of_Pegylated_Interferon_plus_Ribavirin_in_HIV_and_Hepatitis_C_Virus_Coinfected_Patients_with_Advanced_Immunosuppression_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19772388/full_citation/Efficacy_and_Safety_of_Pegylated_Interferon_plus_Ribavirin_in_HIV_and_Hepatitis_C_Virus_Coinfected_Patients_with_Advanced_Immunosuppression_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19772388/Efficacy_and_Safety_of_Pegylated_Interferon_plus_Ribavirin_in_HIV_and_Hepatitis_C_Virus_Coinfected_Patients_with_Advanced_Immunosuppression_">Find Related Articles</a> </description></item><item><title>A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19771431/full_citation/A_phase_II_study_of_combination_of_pegylated_interferon_alfa_2a_and_capecitabine_in_locally_advanced_or_metastatic_renal_cell_cancer_</link><description>Sunela KL, Koskinen S, Kellokumpu-Lehtinen PL <br/><span class="title">A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer chemotherapy and pharmacology">Cancer Chemother Pharmacol 2009 Sep 22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19771431/abstract/A_phase_II_study_of_combination_of_pegylated_interferon_alfa_2a_and_capecitabine_in_locally_advanced_or_metastatic_renal_cell_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19771431/full_citation/A_phase_II_study_of_combination_of_pegylated_interferon_alfa_2a_and_capecitabine_in_locally_advanced_or_metastatic_renal_cell_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19771431/A_phase_II_study_of_combination_of_pegylated_interferon_alfa_2a_and_capecitabine_in_locally_advanced_or_metastatic_renal_cell_cancer_">Find Related Articles</a> </description></item><item><title>Genomics: Hepatitis C virus gets personal.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19759611/full_citation/Genomics:_Hepatitis_C_virus_gets_personal_</link><description>Iadonato SP, Katze MG <br/><span class="title">Genomics: Hepatitis C virus gets personal. [Comment, News]</span><br/><span class="source" title="Nature">Nature 2009 Sep 17; 461(7262):357-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19759611/full_citation/Genomics:_Hepatitis_C_virus_gets_personal_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19759611/Genomics:_Hepatitis_C_virus_gets_personal_">Find Related Articles</a> </description></item><item><title>Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19758237/full_citation/Treatment_with_PEG_interferon_and_Ribavirin_for_Chronic_Hepatitis_C_Increases_Neutrophil_and_Monocyte_Chemotaxis_</link><description>Giorgini A, Capsoni F, Podda M, et al. <br/><span class="title">Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis. [Journal Article]</span><br/><span class="source" title="Annals of the New York Academy of Sciences">Ann N Y Acad Sci 2009 Sep.:847-57.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19758237/abstract/Treatment_with_PEG_interferon_and_Ribavirin_for_Chronic_Hepatitis_C_Increases_Neutrophil_and_Monocyte_Chemotaxis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19758237/full_citation/Treatment_with_PEG_interferon_and_Ribavirin_for_Chronic_Hepatitis_C_Increases_Neutrophil_and_Monocyte_Chemotaxis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19758237/Treatment_with_PEG_interferon_and_Ribavirin_for_Chronic_Hepatitis_C_Increases_Neutrophil_and_Monocyte_Chemotaxis_">Find Related Articles</a> </description></item></channel></rss>